Follow us on Google News (click on ☆)
A recent study presented at the annual meeting of the American College of Allergy, Asthma and Immunology reveals that vaccinated children develop fewer infections and allergic problems than their unvaccinated peers, opening promising perspectives for the management of this condition.
The study involved over 11,000 children diagnosed with atopic dermatitis, the medical term for eczema. Researchers compared two carefully matched groups based on age, sex, and medical history, excluding children who had previously contracted COVID-19 or had serious medical conditions.
COVID-19 vaccination could help children with eczema fight infections and allergies, offering protection that goes far beyond the virus itself.
The results show that vaccinated children experienced significantly fewer infections such as ear infections, pneumonia, bronchitis, and various skin infections, with risk reductions of up to 52% for some conditions.
Beyond protection against infections, vaccination also appears to favorably influence the progression of allergic diseases. Researchers observed a notable decrease in the incidence of asthma, allergic rhinitis, and food anaphylactic reactions in vaccinated children. These conditions are part of what doctors call the 'atopic march,' this natural progression where eczema often precedes the appearance of other respiratory and food allergies.
The mechanism explaining these extended benefits might lie in immune system modulation. Since atopic dermatitis is characterized by an imbalance in immune defenses, vaccination could help rebalance certain excessive inflammatory responses. This hypothesis is supported by the fact that the onset of many conditions was delayed in vaccinated children, suggesting a lasting protective effect beyond simply preventing coronavirus.
These discoveries reinforce the importance of vaccination in children with eczema, a population particularly vulnerable to infections. While many parents worry about potential side effects, this study provides reassuring information regarding vaccine safety and its additional benefits. However, researchers emphasize the need for further investigations to better understand the biological mechanisms underlying these extended protective effects.
The atopic march: understanding the evolution of allergies in children
The atopic march refers to the natural progression of allergic diseases that often begins in early childhood with eczema, then evolves into asthma and allergic rhinitis. This phenomenon is explained by a genetic predisposition to develop excessive immune reactions against normally harmless substances like pollen or dust mites.
Eczema generally constitutes the first visible manifestation of this increased sensitivity. The skin, a natural protective barrier, presents abnormalities that allow allergens to penetrate more easily into the body. This early exposure triggers a cascade of inflammatory reactions that prepares the ground for the later development of other allergies.
Over time, the immune system continues to react excessively, extending its reactions to other organs like the airways. This is how asthma and allergic rhinitis can appear, often between ages 3 and 7. This progression is not systematic but concerns about one third of children with severe eczema.
Understanding this natural evolution allows for better anticipation and prevention of complications. Early interventions, such as proper management of eczema and avoidance of identified allergens, can sometimes slow down or modify the course of this atopic march.
The immune system in atopic dermatitis
Atopic dermatitis results from a complex interaction between genetic and environmental factors that disrupt the normal functioning of the immune system. In affected individuals, an imbalance is observed between two types of lymphocytes, the immune cells that coordinate our defenses.
More specifically, Th2 lymphocytes, responsible for reactions against parasites and allergens, are overactivated to the detriment of Th1 lymphocytes that fight against viral and bacterial infections. This imbalance leads to excessive production of immunoglobulin E, antibodies involved in allergic reactions.
The skin barrier also plays an essential role. In atopic patients, the skin has defects in the proteins that ensure its cohesion, such as filaggrin. This increased permeability allows allergens and microbes to penetrate more easily, triggering local and systemic inflammatory reactions.
These immune disturbances explain why children with eczema are more sensitive to infections and often develop other allergies. Any intervention capable of rebalancing this dysregulated immune system could therefore have extended benefits, beyond simply protecting against a specific disease.